Bio-Techne (TECH) Other Operating Expenses (2009 - 2014)

Bio-Techne (TECH) posted quarterly Other Operating Expenses of -$2.4 million for Q3 2014, down 345.49% year-over-year from $965421.1 in Q3 2013, and down 345.49% quarter-over-quarter from -$532000.0 in Q3 2013.

Bio-Techne (TECH) Other Operating Expenses (2009 - 2014) Analysis & Trends

Bio-Techne's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$2.4 million for Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Bio-Techne 11.33 Bn 11.12 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Sep 30, 2014 -2.37 Mn
Sep 30, 2013 -532,000.00
Jun 30, 2010 -720,000.00
Mar 31, 2010 240,000.00
Dec 31, 2009 240,000.00
Sep 30, 2009 240,000.00